Topical use of arthritis drug provides relief for dry eye disease, study suggests
Thursday, April 18, 2013 - 16:35
in Health & Medicine
An estimated nine million people in the United State alone suffer from significant dry eye disorder. Researchers have shown that topical anakinra (Kineret; Amgen Inc.), a recombinant version of human IL-1Ra approved for treatment of rheumatoid arthritis, significantly reduced dry eye symptoms.